Pre-clinical PK/PD Analystv1.0.0

Perform non-compartmental analysis on preclinical rat PK data to compute AUC, Cmax, Tmax, and half-life for an Investigational New Drug application. This automated workflow ensures reproducible results and clear documentation of assumptions.

Analyze multi-dose PK data from preclinical studies to determine the optimal starting dose for Phase I clinical trials. The skill provides clear output boundaries and explicit assumptions about dose proportionality and clearance.

Compare PK parameters (e.g., AUC, half-life, bioavailability) across several lead compounds to rank candidates for further development. The structured execution path ensures consistent comparison criteria.

Use the skill as an open-source, scriptable alternative to commercial PK software like WinNonlin. Generate audit-ready PK reports with validated Python scripts for regulatory submissions.

Automate the generation of a PK report template from raw concentration-time data, including AUC, clearance, and volume of distribution. The workflow enforces a structured output format with assumptions explicitly stated.

Offer a cloud-based platform that integrates this skill for on-demand PK/PD analysis. Revenue is generated via monthly subscriptions or per-analysis fees, targeting small biotechs without in-house PK expertise.

Provide fee-for-service PK/PD analysis using this skill as a core tool. Consultants can deliver validated results with audit trails, charging per project or hourly.

Package the skill as part of a data integrity and compliance service for regulatory filings. Revenue comes from one-time setup fees plus per-submission charges, ensuring reproducibility for IND/NDA packages.